69 withdrawn. 69 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 69 | Withdrawn 69 |
Follow Neoplasms: new trials by email Literature Review of Neoplasms trials Research Report on Neoplasms
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of Ropeginterferon Alfa 2b (P1101) for Patients With Polycythemia Vera Ropeginterferon alfa-2b, Phlebotomy and aspirin - Polycythemia Vera, Myeloproliferative Neoplasm | Phase 4 | Withdrawn | PharmaEssentia | 2026-08-01 | 2026-07-31 | |
| Surgical or Radiotherapeutic Intervention Concerning Large Singular Stable to Progressive Metastases in Patients With BRAFV600-mutated Melanoma Receiving Treatment With Encorafenib + Binimetinib Encorafenib & Binimetinib Treatment - Melanoma BRAF V600E/K Mutated | Phase 4 | Withdrawn | SRH Wald-Klinikum Gera GmbH | 2025-08-01 | 2026-04-21 | |
| Post-operative Adjuvant Therapy w/wo GammaTile + Systemic Therapy Gamma Tile-Surgically Targeted Radiation Therapy (STaRT), Stereotactic Radiation Therapy - Glioblastoma | Phase 4 | Withdrawn | GT Medical Technologies, Inc. | 2025-05-01 | 2025-04-10 | |
| Evaluation of Neuroma Perfusion with Indocyanine Green Fluorescence Angiography Indocyanine green - Neuroma, Neuroma Amputation | Phase 4 | Withdrawn | Northwestern University | 2024-12-28 | 2025-01-01 | |
| Prostate MRI and Pylarify PSMA PET/CT Pylarify Piflufolastat Flourine-18 (18F-DCFPyL) - Prostate Cancer | Phase 4 | Withdrawn | Corewell Health East | 2024-10-01 | 2025-01-03 | |
| Antimicrobial Revision in Persistent Febrile Neutropenia Meropenem, Micafungin - Febrile Neutropenia | Phase 4 | Withdrawn | Wake Forest University Health Sciences | 2024-08-01 | 2024-09-19 | |
| A Trial to Evaluate Efficacy of Reinduction With Nadofaragene Firadenovec in Subjects With CIS ± High-grade Ta/T1 and no Complete Response to First Nadofaragene Firadenovec Dose. nadofaragene firadenovec - Bladder Cancer, Ta/T1 | Phase 4 | Withdrawn | Ferring Pharmaceuticals | 2024-06-17 | 2024-11-22 | |
| Mood Disorders in Head and Neck Cancer Patients Venlafaxine - Depressive Disorder, Head and Neck Cancer | Phase 4 | Withdrawn | University of Alabama at Birmingham | 2024-01-05 | 2025-02-04 | |
| Reducing Port Access Pain and Clinic Wait Time: An Evaluation of EMLA Cream Versus nüm™ Vapocoolant Spray Num Vapocoolant Spray, EMLA Cream - Pediatric Cancer | Phase 4 | Withdrawn | Marianne Hutti | 2023-12-23 | 2024-11-14 | |
| Tirbanibulin 1% Ointment for the Treatment of Actinic Keratosis on the Back of the Hands Tirbanibulin - Actinic Keratoses | Phase 4 | Withdrawn | Medical University of Graz | 2023-10-01 | 2024-05-30 | |
| Letrozole Versus Hormonal Preparation in Frozen Cycles of PCOS Patients. Letrozole 2.5mg - Frozen Embryo Transfer, Polycystic Ovarian Disease | Phase 4 | Withdrawn | Dubai Fertility Center | 2023-08-01 | 2024-02-20 | |
| Surgical Myomectomy Followed by Oral Myfembree Versus Standard of Care Trial (SOUL) Myfembree Oral Product - Metrorrhagia, Pelvic Pain | Phase 4 | Withdrawn | University of Chicago | 2022-11-20 | 2026-06-05 | |
| Metformin Use to Reduce Disparities in Newly Diagnosed Breast Cancer Metformin Extended Release Oral Tablet - Breast Cancer Stage, Insulin Resistance | Phase 4 | Withdrawn | Woman's | 2022-09-01 | 2023-07-06 | |
| CEFtolozane-Tazobactam for the Empiric Anti-bacterial Treatment of Neutropenic Fever in Hematology Patients Ceftolozane-tazobactam IV - Neutropenia, Febrile, Hematologic Cancer | Phase 4 | Withdrawn | Hamad Medical Corporation | 2022-08-01 | 2023-08-14 | |
| A Multicenter In-class Transition Study of Ixazomib Combined With Pomalidomide and Dexamethasone or With Lenalidomide and Dexamethasone in Adults With Relapsed/Refractory Multiple Myeloma Ixazomib, Pomalidomide, Lenalidomide - Multiple Myeloma | Phase 4 | Withdrawn | Takeda | 2022-06-30 | 2022-05-03 | |
| A Study to Evaluate Indocyanine Green Lymphangiography to Improve Lymphadenectomy in Gastric Cancer Patients Indocyanine green - Gastric Cancer | Phase 4 | Withdrawn | Mayo Clinic | 2022-01-01 | 2023-07-19 | |
| Letrozole for Frozen Embryo Transfer (FET) in Patients With Polycystic Ovary Syndrome (PCOS) Letrozole, estradiol valerate - Infertility, Female, Polycystic Ovary Syndrome | Phase 4 | Withdrawn | CRG UZ Brussel | 2020-12-01 | 2021-01-08 | |
| Dynamics and Tracer Distribution of Tilmanocept in Early Stage Breast Cancer Tilmanocept, Nanocolloid - Breast Cancer, Sentinel Lymph Node | Phase 4 | Withdrawn | University Hospital, Ghent | 2020-11-24 | 2021-05-14 | |
| Barretts oEsophageal Resection With Steroid Therapy Trial Prednisolone, Placebo Oral Tablet - Barrett Esophagus, Esophageal Stenosis | Phase 4 | Withdrawn | Professor Michael Bourke | 2020-03-09 | 2025-03-27 | |
| Effect of Standard of Care Reduced Dose Versus Full Dose Buprenorphine/Naloxone in the Perioperative Period on Pain Control and Post-Operative Opioid Use Disorder Symptoms Buprenorphine/naloxone - Opioid-use Disorder, Opioid Use Disorder, Mild | Phase 4 | Withdrawn | Massachusetts General Hospital | 2019-10-01 | 2025-12-31 |
Showing 20 of 69. Sign in to see all of them.
Breast Neoplasms (10) · Polycystic Ovary Syndrome (8) · Infertility (5) · Liver Neoplasms (4) · Carcinoma, Hepatocellular (3) · Colorectal Neoplasms (3) · Head and Neck Neoplasms (3) · Lung Neoplasms (3) · Multiple Myeloma (3) · Neoplasm Metastasis (3) · Pain, Postoperative (3) · Anovulation (2) · Febrile Neutropenia (2) · Leiomyoma (2)
Neoplasms by Site (37) · Neoplasms by Histologic Type (22) · Urogenital Diseases (15) · Digestive System Diseases (14) · Digestive System Neoplasms (13) · Female Urogenital Diseases (13) · Female Urogenital Diseases and Pregnancy Complications (13) · Genital Diseases (13) · Skin Diseases (13) · Skin and Connective Tissue Diseases (13) · Endocrine System Diseases (12) · Hemic and Lymphatic Diseases (12) · Genital Diseases, Female (11) · Pathological Conditions, Signs and Symptoms (11)
Letrozole (3) · Metformin (3) · Acitretin (2) · Bevacizumab (2) · Clomiphene (2) · Estradiol (2) · Gentamicins (2) · Indocyanine Green (2) · Lidocaine (2) · Progesterone (2) · Sperm Injections, Intracytoplasmic (2) · 2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid (1) · 5-aminolevulinic acid hexyl ester (1) · Alloderm (1) · Amino Acids (1)
University Magna Graecia (3) · Hoffmann-La Roche (2) · Lund University (2) · Mohamed Sayed Abdelhafez (2) · AstraZeneca (1) · Augusta University (1) · Boston Children's Hospital (1) · Boston Scientific Corporation (1) · CRG UZ Brussel (1) · Centre Hospitalier Universitaire, Amiens (1) · Centre hospitalier de l'Université de Montréal (CHUM) (1) · China Medical University, China (1) · Corewell Health East (1) · DFINE Inc. (1) · Dana-Farber Cancer Institute (1)
United States (22) · Italy (5) · Canada (4) · Egypt (3) · Belgium (2) · Brazil (2) · China (2) · France (2) · Sweden (2) · United Kingdom (2) · Argentina (1) · Australia (1) · Austria (1) · Germany (1) · Japan (1)
Achille Tolino, MD (3) · Francesco Orio, MD (3) · Stefano Palomba, MD (3) · Ahmed Gibreel, Dr (2) · Mohamed S Abdelhafez, Dr (2) · Ali S. Omrani, FRCP (1) · Antonio Pascual, Dr., PhD (1) · Cynthia Harper-Weinstein (1) · David Burling (1) · Deidre Cohen (1)
PMID 17917842, PMID 19574236, PMID 19645909, PMID 22027076, PMID 10950834, PMID 18607963, PMID 24249997, PMID 24310051, PMID 25559471, PMID 26988861, PMID 37526194, PMID 38954680
2019 (1), P30CA015704 (1)